Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute

Yahoo FinanceMay 14 22:01

10-Q: Quarterly report

SEC announcementMay 14 04:10 · Announcements

Scilex Provides Information To Stockholders Regarding Manipulative And Naked Short Selling Of Its Common Stock

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for t

BenzingaMay 13 21:08

Scilex Holding Is Maintained at Buy by HC Wainwright & Co.

Scilex Holding Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 4 04:07

HC Wainwright & Co. : The Scilex Holding (SCLX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $8.00.

HC Wainwright & Co. : The Scilex Holding (SCLX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $8.00.

Zhitong FinanceMay 4 04:01

HC Wainwright & Co. Maintains Buy on Scilex Holding, Lowers Price Target to $8

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Scilex Holding (NASDAQ:SCLX) with a Buy and lowers the price target from $12 to $8.

BenzingaMay 4 03:57